136 related articles for article (PubMed ID: 23980865)
1. Pharmacokinetics and absorption of the anticancer agents dasatinib and GDC-0941 under various gastric conditions in dogs--reversing the effect of elevated gastric pH with betaine HCl.
Pang J; Dalziel G; Dean B; Ware JA; Salphati L
Mol Pharm; 2013 Nov; 10(11):4024-31. PubMed ID: 23980865
[TBL] [Abstract][Full Text] [Related]
2. The use of betaine HCl to enhance dasatinib absorption in healthy volunteers with rabeprazole-induced hypochlorhydria.
Yago MR; Frymoyer A; Benet LZ; Smelick GS; Frassetto LA; Ding X; Dean B; Salphati L; Budha N; Jin JY; Dresser MJ; Ware JA
AAPS J; 2014 Nov; 16(6):1358-65. PubMed ID: 25274610
[TBL] [Abstract][Full Text] [Related]
3. Impact of food and the proton pump inhibitor rabeprazole on the pharmacokinetics of GDC-0941 in healthy volunteers: bench to bedside investigation of pH-dependent solubility.
Ware JA; Dalziel G; Jin JY; Pellett JD; Smelick GS; West DA; Salphati L; Ding X; Sutton R; Fridyland J; Dresser MJ; Morrisson G; Holden SN
Mol Pharm; 2013 Nov; 10(11):4074-81. PubMed ID: 24099279
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the rat model for preclinical evaluation of pH-dependent oral absorption in humans.
Lubach JW; Chen JZ; Hau J; Imperio J; Coraggio M; Liu L; Wong H
Mol Pharm; 2013 Nov; 10(11):3997-4004. PubMed ID: 23961831
[TBL] [Abstract][Full Text] [Related]
5. Gastric reacidification with betaine HCl in healthy volunteers with rabeprazole-induced hypochlorhydria.
Yago MR; Frymoyer AR; Smelick GS; Frassetto LA; Budha NR; Dresser MJ; Ware JA; Benet LZ
Mol Pharm; 2013 Nov; 10(11):4032-7. PubMed ID: 23980906
[TBL] [Abstract][Full Text] [Related]
6. Development of a canine model to enable the preclinical assessment of pH-dependent absorption of test compounds.
Fancher RM; Zhang H; Sleczka B; Derbin G; Rockar R; Marathe P
J Pharm Sci; 2011 Jul; 100(7):2979-88. PubMed ID: 21254068
[TBL] [Abstract][Full Text] [Related]
7. Influence of H2-receptor antagonists and proton pump inhibitors on dasatinib pharmacokinetics in Japanese leukemia patients.
Takahashi N; Miura M; Niioka T; Sawada K
Cancer Chemother Pharmacol; 2012 Apr; 69(4):999-1004. PubMed ID: 22147077
[TBL] [Abstract][Full Text] [Related]
8. Phase I study of the effect of gastric acid pH modulators on the bioavailability of oral dasatinib in healthy subjects.
Eley T; Luo FR; Agrawal S; Sanil A; Manning J; Li T; Blackwood-Chirchir A; Bertz R
J Clin Pharmacol; 2009 Jun; 49(6):700-9. PubMed ID: 19395585
[TBL] [Abstract][Full Text] [Related]
9. Using absorption simulation and gastric pH modulated dog model for formulation development to overcome achlorhydria effect.
Mitra A; Kesisoglou F; Beauchamp M; Zhu W; Chiti F; Wu Y
Mol Pharm; 2011 Dec; 8(6):2216-23. PubMed ID: 21981752
[TBL] [Abstract][Full Text] [Related]
10. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
[TBL] [Abstract][Full Text] [Related]
11. Using pH Gradient Dissolution with In-Situ Flux Measurement to Evaluate Bioavailability and DDI for Formulated Poorly Soluble Drug Products.
Li J; Tsinman K; Tsinman O; Wigman L
AAPS PharmSciTech; 2018 Oct; 19(7):2898-2907. PubMed ID: 30209787
[TBL] [Abstract][Full Text] [Related]
12. Modification of gastric pH in the fasted dog.
Polentarutti B; Albery T; Dressman J; Abrahamsson B
J Pharm Pharmacol; 2010 Apr; 62(4):462-9. PubMed ID: 20604835
[TBL] [Abstract][Full Text] [Related]
13. Impaired drug absorption due to high stomach pH: a review of strategies for mitigation of such effect to enable pharmaceutical product development.
Mitra A; Kesisoglou F
Mol Pharm; 2013 Nov; 10(11):3970-9. PubMed ID: 23844623
[TBL] [Abstract][Full Text] [Related]
14. pH-dependent dissolution in vitro and absorption in vivo of weakly basic drugs: development of a canine model.
Zhou R; Moench P; Heran C; Lu X; Mathias N; Faria TN; Wall DA; Hussain MA; Smith RL; Sun D
Pharm Res; 2005 Feb; 22(2):188-92. PubMed ID: 15783065
[TBL] [Abstract][Full Text] [Related]
15. Meal Effects Confound Attempts to Counteract Rabeprazole-Induced Hypochlorhydria Decreases in Atazanavir Absorption.
Faber KP; Wu HF; Yago MR; Xu X; Kadiyala P; Frassetto LA; Benet LZ
Pharm Res; 2017 Mar; 34(3):619-628. PubMed ID: 28028768
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Acid Tolerance of Drugs Using Rats and Dogs Controlled for Gastric Acid Secretion.
Kosugi Y; Yamamoto S; Sano N; Furuta A; Igari T; Fujioka Y; Amano N
J Pharm Sci; 2015 Sep; 104(9):2887-93. PubMed ID: 25720462
[TBL] [Abstract][Full Text] [Related]
17. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
Kamath AV; Wang J; Lee FY; Marathe PH
Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of motilin-induced phase III contractions by pentagastrin in Heidenhain pouch dogs.
Yamamoto O; Matsunaga Y; Shiba Y; Haga N; Sano I; Itoh Z
J Pharmacol Exp Ther; 1994 Dec; 271(3):1471-6. PubMed ID: 7996460
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Gastric pH on the Pharmacokinetics-pharmacodynamics of Naphthoquine in Rodents, as well as in Human Predicted Using a PBPK Model.
Xie Y; Liu H; Chen X; Xing J
Curr Drug Metab; 2021; 22(5):363-371. PubMed ID: 33511926
[TBL] [Abstract][Full Text] [Related]
20. Effect of Microenvironmental pH Modulation on the Dissolution Rate and Oral Absorption of the Salt of a Weak Acid - Case Study of GDC-0810.
Hou HH; Jia W; Liu L; Cheeti S; Li J; Nauka E; Nagapudi K
Pharm Res; 2018 Jan; 35(2):37. PubMed ID: 29380076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
